An important new bill addresses this situation. Action Alert! On July 25, famed civil rights attorney Jonathan Emord will be hosting a briefing on Capitol Hill about the FDA’s refusal to allow terminally ill patients access to experimental treatments. In… Read More ›
Clinical trial
Review of group-based cancer trials reveals flaws in studies’ design and analysis
COLUMBUS, Ohio – A new study reviewing 75 group-randomized cancer trials over a five-year stretch shows that fewer than half of those studies used appropriate statistical methods to analyze the results. The review suggests that some trials may have reported… Read More ›
Engineering Evil 